Search

everythinglearnresearchcommunity

for

Search:↓

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

Overexpressing ATF3 in mice's epithelial cells may lead to oral cancer.

Trichostasis spinulosa is a common but often unnoticed skin condition involving bundled vellus hairs, especially in people with darker skin or UV exposure.

Corticosteroid injections for hair loss may cause eye problems, so caution is needed.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

An adult with a rare skin condition improved with tazarotene treatment.

The meeting concluded with optimism about increasing research and better management of vitiligo.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

A baby with a skin condition improved with treatment but developed a rare form of the condition affecting only his trunk.

Both concentrations of triamcinolone acetonide are equally effective and safe for treating patchy alopecia areata.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

Axitinib treatment turned a man's grey hair back to black.

A rare skin condition in a boy is likely due to a specific genetic mutation pattern.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

The laser effectively removes hair for skin types IV and V but is less effective for type VI.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Ultraviolet light helped hair growth more effectively than triamcinolone acetonide.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

A TP63 gene mutation causes significant hair loss and mild skin, nail, and tooth abnormalities.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.